Table: Phoenixbio -2025/26 group results

PhoenixBio

15/05/2026 07:40

May 15 (Reuters)- 
          Phoenixbio Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended       Year ended       Year to        NEXT     
              Mar 31, 2026     Mar 31, 2025   Mar 31, 2027      YEAR       
                 LATEST          YEAR-AGO        COMPANY        COMPANY    
                 RESULTS         RESULTS        FORECAST      H1 FORECAST  
  Sales           1.57             1.54           1.61          671 mln    
               (+1.6 pct)      (-10.1 pct)     (+2.9 pct)     (-11.2 pct)  
  Operating      82 mln        loss 142 mln      85 mln       loss 96 mln  
                                               (+3.7 pct)                  
  Recurring      131 mln       loss 155 mln      87 mln       loss 95 mln  
                                               (-33.5 pct)                 
  Net
  Net            125 mln       loss 448 mln      76 mln       loss 98 mln  
                                               (-38.6 pct)                 
  EPS           30.81 yen    loss 110.99 yen    18.90 yen   loss 24.30 yen 
  Ann Div          NIL             NIL             NIL                     
  -Q2 Div          NIL             NIL             NIL                     
  -Q4 Div          NIL             NIL             NIL                     
  
  NOTE - Phoenixbio Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T